Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study

✍ Scribed by Mariette, X.; Seror, R.; Quartuccio, L.; Baron, G.; Salvin, S.; Fabris, M.; Desmoulins, F.; Nocturne, G.; Ravaud, P.; De Vita, S.

• Book ID: 125856410
• Publisher: BMJ Publishing Group
• Year: 2013
• Tongue: English
• Weight: 968 KB
• Volume: 74
• Category: Article
• ISSN: 0003-4967
• DOI: 10.1136/annrheumdis-2013-203991